confirmed that genetically elevated IGF-1 was causally linked to breast cancer, independent of IGFBP-3 (IGF-binding protein-3) (OR per 5 nmol/L ≈ 1.11; 95% CI, 1.02–1.21) (35). This evidence concerns the gene IGF1 and breast cancer.